Skip to main content
Smart Investors Daily
ES

NASDAQ · ESTA

Establishment Labs Holdings Inc.

Healthcare · Medical - Devices

$64.06

Up+$1.02 (+1.62%)

Updated Oct 3, 2026, 10:48 AM

SID Score

4.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.11B
P/E ratio
-25.93
Dividend yield
0.00%
52-week range
$38.38 – $97.59
Volume
309.23K
Avg. volume
456.66K

Price performance · ESTA

ESTA price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 2, 2026

ESTA closed at $64.06 after 20 trading sessions, down 13.77% for the selected period.

Last close
$64.06
Period change
-13.77%
Period low
$63.04
Period high
$75.29
Daily close
View OHLC price history
ESTA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 2, 2026$63.99$65.30$62.40$64.06309.23K
Oct 1, 2026$63.53$65.035$61.89$63.04388.6K
Sep 30, 2026$64.02$64.43$62.72$64.17555.71K
Sep 29, 2026$64.90$65.84$62.29$63.70516.87K
Sep 28, 2026$65.55$66.19$64.15$65.34345.9K
Sep 25, 2026$65.45$67.36$65.00$65.97265.01K
Sep 24, 2026$67.31$67.50$65.30$65.58372.29K
Sep 23, 2026$69.93$69.93$67.09$67.76319.17K
Sep 22, 2026$68.70$71.61$68.38$70.24281.11K
Sep 21, 2026$69.74$69.97$67.53$67.74258.89K
Sep 18, 2026$69.42$70.14$68.3166$69.30238.51K
Sep 17, 2026$72.66$72.66$69.23$69.56313.21K
Sep 16, 2026$71.53$72.41$70.54$71.16211.85K
Sep 15, 2026$71.47$72.07$70.13$71.48210.44K
Sep 14, 2026$70.69$71.97$70.2504$71.92291.45K
Sep 11, 2026$72.58$73.63$70.175$70.94281.97K
Sep 10, 2026$73.70$74.39$71.125$71.39267.74K
Sep 9, 2026$74.77$75.40$73.58$74.51317.09K
Sep 8, 2026$74.08$75.76$72.3146$75.29433.85K
Sep 4, 2026$71.97$75.045$71.60$74.29357.45K

Latest ESTA news

The latest Smart Investors Daily articles mentioning ESTA.

ESTA research

Overview

Company profile and research snapshot.

Company profile

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$82.50
Implied upside
—
Analysts
—
ESTA recent ratings
DateFirmRatingTarget
Sep 1, 2026BTIGBuy—
Aug 13, 2026CitigroupBuy—
Aug 7, 2026JP MorganOverweight—
Aug 6, 2026NeedhamBuy—
Aug 6, 2026BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 21, 2026

Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

NEW YORK, September 21, 2026--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of new clinical and scientific data supporting Breast Tissue Preservation and its Minimally Invasive Platform. Establishment Labs also announced the product line extensions of both Mia® and Preservé™ with new sizes and supporting tools. The announcement

Yahoo · Sep 1, 2026

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

Equity Insider News Commentary - The global medical aesthetics market has quietly become one of the most durable growth stories in healthcare. Multiple market-research firms size it at roughly US$22 billion to US$23 billion in 2026, with projections reaching approximately US$40 billion by 2031 at a compound annual growth rate near 12 percent, and other forecasts running higher still over longer horizons. The drivers are structural: an aging population, rising disposable incomes, the normalizatio

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.